Prognostic value of longitudinal liver stiffness measurements in patients with steatotic liver disease – a retrospective cohort study
Zeitschrift für Gastroenterologie · 01.05.2024 · 62 (05) · e480
DOI: 10.1055/s-0044-1786887 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.05.2024. Verfasst von L. Fritz.
Abstract (Originalsprache)
Background & Aims: Steatotic liver disease (SLD) has become the most prevalent liver disease. Non-invasive methods for assessing liver fibrosis and predicting liver-related complications, such as liver stiffness measurement (LSM), need to be investigated and validated for SLD. Therefore, we studied changes in LSM and their ability to predict hepatic decompensation in SLD patients.
Methods
This retrospective study was conducted at the Medical University of Vienna, involving 540 patients with metabolic dysfunction-related steatotic liver disease or alcohol-related (steatotic) liver disease. Patients were included if they had at least two reliable LSMs taken≥180 days apart and were categorized according to their liver disease severity: non-advanced chronic liver disease (non-ACLD), compensated ACLD (cACLD) and decompensated ACLD (dACLD). The difference between the first (Baseline-LSM) and second reliable LSM (Updated-LSM) was calculated to assess changes in LSM.
Results
299 patients (55.4%) showed any decrease in LSM while 208 patients (38.5%) showed a decrease of≥20%. Changes in LSM were more pronounced in cACLD (n=148, 27.4%) and dACLD (n=58, 10.7%). During a median follow-up time of 54.4 months, 59 patients (10.9%) experienced hepatic decompensation in the overall cohort (30 with cACLD (18.3%) and 27 with dACLD (46.6%)). Baseline-LSM (AUROC: 0.861 [CI95%, 0.774-0.947]) and Updated-LSM (AUROC: 0.895 [CI95%, 0.814-0.976]) were numerically more accurate in predicting hepatic decompensation within 24 months compared to laboratory parameters. The Baveno VII criteria for a clinically significant decrease in LSM distinguished the high- from the low-risk subgroup (cumulative incidence at 24 months: 1.1% vs. 22.0%, hazard ratio: 8.49 (CI95%, 3.07-23.46; p
Zitieren
APA
Fritz, L. (2024). Prognostic value of longitudinal liver stiffness measurements in patients with steatotic liver disease – a retrospective cohort study. Zeitschrift für Gastroenterologie, 62(05), e480. https://doi.org/10.1055/s-0044-1786887
Vancouver
Fritz L. Prognostic value of longitudinal liver stiffness measurements in patients with steatotic liver disease – a retrospective cohort study. Zeitschrift für Gastroenterologie. 2024;62(05):e480. doi:10.1055/s-0044-1786887
BibTeX
@article{Fritz2024,
author = {Fritz, L.},
title = {Prognostic value of longitudinal liver stiffness measurements in patients with steatotic liver disease – a retrospective cohort study},
journal = {Zeitschrift für Gastroenterologie},
year = {2024},
volume = {62},
number = {05},
pages = {e480},
doi = {10.1055/s-0044-1786887}
}
EUVIMED